[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cardiology Radiopharmaceuticals Market Growth (Status and Outlook) 2023-2029

August 2023 | 104 pages | ID: G3E5270578C6EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our (LP Info Research) latest study, the global Cardiology Radiopharmaceuticals market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Cardiology Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.

The research report highlights the growth potential of the global Cardiology Radiopharmaceuticals market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Cardiology Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cardiology Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cardiology Radiopharmaceuticals market.

Key Features:

The report on Cardiology Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Cardiology Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Technetium-99, Fluorine-18), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cardiology Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Cardiology Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Cardiology Radiopharmaceuticals industry. This include advancements in Cardiology Radiopharmaceuticals technology, Cardiology Radiopharmaceuticals new entrants, Cardiology Radiopharmaceuticals new investment, and other innovations that are shaping the future of Cardiology Radiopharmaceuticals.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cardiology Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Cardiology Radiopharmaceuticals product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cardiology Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cardiology Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cardiology Radiopharmaceuticals market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cardiology Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cardiology Radiopharmaceuticals market.

Market Segmentation:

Cardiology Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Technetium-99
  • Fluorine-18
  • Gallium-67
  • Others
Segmentation by application
  • Therapeutic Use
  • Diagnostic Use
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GE Healthcare
  • Cardinal Health
  • Curium Pharma
  • Lantheus Medical Imaging, Inc.
  • Eczac?baє? Monrol Nuclear Products
  • Novartis International AG
  • Siemens
  • China Isotope & Radiation
  • Yantai Dongcheng Pharmaceutical
  • Jubilant Life Sciences
  • Bracco
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cardiology Radiopharmaceuticals Market Size 2018-2029
  2.1.2 Cardiology Radiopharmaceuticals Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cardiology Radiopharmaceuticals Segment by Type
  2.2.1 Technetium-99
  2.2.2 Fluorine-18
  2.2.3 Gallium-67
  2.2.4 Others
2.3 Cardiology Radiopharmaceuticals Market Size by Type
  2.3.1 Cardiology Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
2.4 Cardiology Radiopharmaceuticals Segment by Application
  2.4.1 Therapeutic Use
  2.4.2 Diagnostic Use
2.5 Cardiology Radiopharmaceuticals Market Size by Application
  2.5.1 Cardiology Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)

3 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SIZE BY PLAYER

3.1 Cardiology Radiopharmaceuticals Market Size Market Share by Players
  3.1.1 Global Cardiology Radiopharmaceuticals Revenue by Players (2018-2023)
  3.1.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Players (2018-2023)
3.2 Global Cardiology Radiopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CARDIOLOGY RADIOPHARMACEUTICALS BY REGIONS

4.1 Cardiology Radiopharmaceuticals Market Size by Regions (2018-2023)
4.2 Americas Cardiology Radiopharmaceuticals Market Size Growth (2018-2023)
4.3 APAC Cardiology Radiopharmaceuticals Market Size Growth (2018-2023)
4.4 Europe Cardiology Radiopharmaceuticals Market Size Growth (2018-2023)
4.5 Middle East & Africa Cardiology Radiopharmaceuticals Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Cardiology Radiopharmaceuticals Market Size by Country (2018-2023)
5.2 Americas Cardiology Radiopharmaceuticals Market Size by Type (2018-2023)
5.3 Americas Cardiology Radiopharmaceuticals Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cardiology Radiopharmaceuticals Market Size by Region (2018-2023)
6.2 APAC Cardiology Radiopharmaceuticals Market Size by Type (2018-2023)
6.3 APAC Cardiology Radiopharmaceuticals Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cardiology Radiopharmaceuticals by Country (2018-2023)
7.2 Europe Cardiology Radiopharmaceuticals Market Size by Type (2018-2023)
7.3 Europe Cardiology Radiopharmaceuticals Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cardiology Radiopharmaceuticals by Region (2018-2023)
8.2 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Type (2018-2023)
8.3 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CARDIOLOGY RADIOPHARMACEUTICALS MARKET FORECAST

10.1 Global Cardiology Radiopharmaceuticals Forecast by Regions (2024-2029)
  10.1.1 Global Cardiology Radiopharmaceuticals Forecast by Regions (2024-2029)
  10.1.2 Americas Cardiology Radiopharmaceuticals Forecast
  10.1.3 APAC Cardiology Radiopharmaceuticals Forecast
  10.1.4 Europe Cardiology Radiopharmaceuticals Forecast
  10.1.5 Middle East & Africa Cardiology Radiopharmaceuticals Forecast
10.2 Americas Cardiology Radiopharmaceuticals Forecast by Country (2024-2029)
  10.2.1 United States Cardiology Radiopharmaceuticals Market Forecast
  10.2.2 Canada Cardiology Radiopharmaceuticals Market Forecast
  10.2.3 Mexico Cardiology Radiopharmaceuticals Market Forecast
  10.2.4 Brazil Cardiology Radiopharmaceuticals Market Forecast
10.3 APAC Cardiology Radiopharmaceuticals Forecast by Region (2024-2029)
  10.3.1 China Cardiology Radiopharmaceuticals Market Forecast
  10.3.2 Japan Cardiology Radiopharmaceuticals Market Forecast
  10.3.3 Korea Cardiology Radiopharmaceuticals Market Forecast
  10.3.4 Southeast Asia Cardiology Radiopharmaceuticals Market Forecast
  10.3.5 India Cardiology Radiopharmaceuticals Market Forecast
  10.3.6 Australia Cardiology Radiopharmaceuticals Market Forecast
10.4 Europe Cardiology Radiopharmaceuticals Forecast by Country (2024-2029)
  10.4.1 Germany Cardiology Radiopharmaceuticals Market Forecast
  10.4.2 France Cardiology Radiopharmaceuticals Market Forecast
  10.4.3 UK Cardiology Radiopharmaceuticals Market Forecast
  10.4.4 Italy Cardiology Radiopharmaceuticals Market Forecast
  10.4.5 Russia Cardiology Radiopharmaceuticals Market Forecast
10.5 Middle East & Africa Cardiology Radiopharmaceuticals Forecast by Region (2024-2029)
  10.5.1 Egypt Cardiology Radiopharmaceuticals Market Forecast
  10.5.2 South Africa Cardiology Radiopharmaceuticals Market Forecast
  10.5.3 Israel Cardiology Radiopharmaceuticals Market Forecast
  10.5.4 Turkey Cardiology Radiopharmaceuticals Market Forecast
  10.5.5 GCC Countries Cardiology Radiopharmaceuticals Market Forecast
10.6 Global Cardiology Radiopharmaceuticals Forecast by Type (2024-2029)
10.7 Global Cardiology Radiopharmaceuticals Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 GE Healthcare
  11.1.1 GE Healthcare Company Information
  11.1.2 GE Healthcare Cardiology Radiopharmaceuticals Product Offered
  11.1.3 GE Healthcare Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 GE Healthcare Main Business Overview
  11.1.5 GE Healthcare Latest Developments
11.2 Cardinal Health
  11.2.1 Cardinal Health Company Information
  11.2.2 Cardinal Health Cardiology Radiopharmaceuticals Product Offered
  11.2.3 Cardinal Health Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Cardinal Health Main Business Overview
  11.2.5 Cardinal Health Latest Developments
11.3 Curium Pharma
  11.3.1 Curium Pharma Company Information
  11.3.2 Curium Pharma Cardiology Radiopharmaceuticals Product Offered
  11.3.3 Curium Pharma Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Curium Pharma Main Business Overview
  11.3.5 Curium Pharma Latest Developments
11.4 Lantheus Medical Imaging, Inc.
  11.4.1 Lantheus Medical Imaging, Inc. Company Information
  11.4.2 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product Offered
  11.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Lantheus Medical Imaging, Inc. Main Business Overview
  11.4.5 Lantheus Medical Imaging, Inc. Latest Developments
11.5 Eczac?baє? Monrol Nuclear Products
  11.5.1 Eczac?baє? Monrol Nuclear Products Company Information
  11.5.2 Eczac?baє? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Offered
  11.5.3 Eczac?baє? Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Eczac?baє? Monrol Nuclear Products Main Business Overview
  11.5.5 Eczac?baє? Monrol Nuclear Products Latest Developments
11.6 Novartis International AG
  11.6.1 Novartis International AG Company Information
  11.6.2 Novartis International AG Cardiology Radiopharmaceuticals Product Offered
  11.6.3 Novartis International AG Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Novartis International AG Main Business Overview
  11.6.5 Novartis International AG Latest Developments
11.7 Siemens
  11.7.1 Siemens Company Information
  11.7.2 Siemens Cardiology Radiopharmaceuticals Product Offered
  11.7.3 Siemens Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Siemens Main Business Overview
  11.7.5 Siemens Latest Developments
11.8 China Isotope & Radiation
  11.8.1 China Isotope & Radiation Company Information
  11.8.2 China Isotope & Radiation Cardiology Radiopharmaceuticals Product Offered
  11.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 China Isotope & Radiation Main Business Overview
  11.8.5 China Isotope & Radiation Latest Developments
11.9 Yantai Dongcheng Pharmaceutical
  11.9.1 Yantai Dongcheng Pharmaceutical Company Information
  11.9.2 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Offered
  11.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Yantai Dongcheng Pharmaceutical Main Business Overview
  11.9.5 Yantai Dongcheng Pharmaceutical Latest Developments
11.10 Jubilant Life Sciences
  11.10.1 Jubilant Life Sciences Company Information
  11.10.2 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Offered
  11.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Jubilant Life Sciences Main Business Overview
  11.10.5 Jubilant Life Sciences Latest Developments
11.11 Bracco
  11.11.1 Bracco Company Information
  11.11.2 Bracco Cardiology Radiopharmaceuticals Product Offered
  11.11.3 Bracco Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Bracco Main Business Overview
  11.11.5 Bracco Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Cardiology Radiopharmaceuticals Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Technetium-99
Table 3. Major Players of Fluorine-18
Table 4. Major Players of Gallium-67
Table 5. Major Players of Others
Table 6. Cardiology Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Cardiology Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 9. Cardiology Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cardiology Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 12. Global Cardiology Radiopharmaceuticals Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Cardiology Radiopharmaceuticals Revenue Market Share by Player (2018-2023)
Table 14. Cardiology Radiopharmaceuticals Key Players Head office and Products Offered
Table 15. Cardiology Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cardiology Radiopharmaceuticals Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Cardiology Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Table 20. Global Cardiology Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Cardiology Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Cardiology Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 24. Americas Cardiology Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 26. Americas Cardiology Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 28. APAC Cardiology Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 30. APAC Cardiology Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 32. APAC Cardiology Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 34. Europe Cardiology Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 36. Europe Cardiology Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 38. Europe Cardiology Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Cardiology Radiopharmaceuticals
Table 47. Key Market Challenges & Risks of Cardiology Radiopharmaceuticals
Table 48. Key Industry Trends of Cardiology Radiopharmaceuticals
Table 49. Global Cardiology Radiopharmaceuticals Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Cardiology Radiopharmaceuticals Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. GE Healthcare Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 54. GE Healthcare Cardiology Radiopharmaceuticals Product Offered
Table 55. GE Healthcare Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. GE Healthcare Main Business
Table 57. GE Healthcare Latest Developments
Table 58. Cardinal Health Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 59. Cardinal Health Cardiology Radiopharmaceuticals Product Offered
Table 60. Cardinal Health Main Business
Table 61. Cardinal Health Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Cardinal Health Latest Developments
Table 63. Curium Pharma Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 64. Curium Pharma Cardiology Radiopharmaceuticals Product Offered
Table 65. Curium Pharma Main Business
Table 66. Curium Pharma Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Curium Pharma Latest Developments
Table 68. Lantheus Medical Imaging, Inc. Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 69. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product Offered
Table 70. Lantheus Medical Imaging, Inc. Main Business
Table 71. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Lantheus Medical Imaging, Inc. Latest Developments
Table 73. Eczac?baє? Monrol Nuclear Products Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 74. Eczac?baє? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Offered
Table 75. Eczac?baє? Monrol Nuclear Products Main Business
Table 76. Eczac?baє? Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Eczac?baє? Monrol Nuclear Products Latest Developments
Table 78. Novartis International AG Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 79. Novartis International AG Cardiology Radiopharmaceuticals Product Offered
Table 80. Novartis International AG Main Business
Table 81. Novartis International AG Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Novartis International AG Latest Developments
Table 83. Siemens Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 84. Siemens Cardiology Radiopharmaceuticals Product Offered
Table 85. Siemens Main Business
Table 86. Siemens Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Siemens Latest Developments
Table 88. China Isotope & Radiation Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 89. China Isotope & Radiation Cardiology Radiopharmaceuticals Product Offered
Table 90. China Isotope & Radiation Main Business
Table 91. China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. China Isotope & Radiation Latest Developments
Table 93. Yantai Dongcheng Pharmaceutical Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 94. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Offered
Table 95. Yantai Dongcheng Pharmaceutical Main Business
Table 96. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Yantai Dongcheng Pharmaceutical Latest Developments
Table 98. Jubilant Life Sciences Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 99. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Offered
Table 100. Jubilant Life Sciences Main Business
Table 101. Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Jubilant Life Sciences Latest Developments
Table 103. Bracco Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 104. Bracco Cardiology Radiopharmaceuticals Product Offered
Table 105. Bracco Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Bracco Main Business
Table 107. Bracco Latest Developments

LIST OF FIGURES

Figure 1. Cardiology Radiopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiology Radiopharmaceuticals Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cardiology Radiopharmaceuticals Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cardiology Radiopharmaceuticals Sales Market Share by Country/Region (2022)
Figure 8. Cardiology Radiopharmaceuticals Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cardiology Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 10. Cardiology Radiopharmaceuticals in Therapeutic Use
Figure 11. Global Cardiology Radiopharmaceuticals Market: Therapeutic Use (2018-2023) & ($ Millions)
Figure 12. Cardiology Radiopharmaceuticals in Diagnostic Use
Figure 13. Global Cardiology Radiopharmaceuticals Market: Diagnostic Use (2018-2023) & ($ Millions)
Figure 14. Global Cardiology Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 15. Global Cardiology Radiopharmaceuticals Revenue Market Share by Player in 2022
Figure 16. Global Cardiology Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Cardiology Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 18. APAC Cardiology Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 19. Europe Cardiology Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Cardiology Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 21. Americas Cardiology Radiopharmaceuticals Value Market Share by Country in 2022
Figure 22. United States Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2022
Figure 27. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 28. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 29. China Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2022
Figure 36. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 37. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 38. Germany Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Cardiology Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 52. APAC Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 53. Europe Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 55. United States Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 56. Canada Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 59. China Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 60. Japan Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 61. Korea Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 63. India Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 64. Australia Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 65. Germany Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 66. France Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 67. UK Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 68. Italy Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 69. Russia Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 70. Spain Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 73. Israel Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Cardiology Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 76. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Application (2024-2029)


More Publications